Abstract
Teriflunomide is an oral disease modifying therapy for relapsing-remitting multiple sclerosis (RRMS). Gastrointestinal (GI) side effects occurred in 1......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
